Insider · CIK 0001780880
Duncan Gallagher
Files at HCAT (Health Catalyst, Inc.). First filing Dec 27, 2024, latest Jan 2, 2025.
In brief
Duncan Gallagher files SEC Form 4 as director at HCAT (Health Catalyst, Inc.). Since Dec 27, 2024, Duncan Gallagher has reported 0 open-market buys worth $0 and 2 open-market sells worth $63k, the latest filed on Jan 2, 2025.
A track record needs three past buys with six months of prices behind them; Duncan Gallagher has 0, so none is measured yet.
The newest scored trade: sold $31k of HCAT on Dec 30, 2024, filed Jan 2, 2025, scored 15 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HCAT: Health Catalyst, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Health Catalyst, Inc. | $31k 4,500 shares | -6% | +2% from low-22% from high | |
| 15Weak | Health Catalyst, Inc. | $31k 4,500 shares | -6% | 0% from low-23% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 30, 2024 | HCAT HEALTH CATALYST INC | 4,500 0.01% of outstanding | $32k | Dec 30, 2024 | $31k |
| Dec 23, 2024 | HCAT HEALTH CATALYST INC | 4,500 0.01% of outstanding | $32k | Dec 23, 2024 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +7,562 | $0.00 | $0 | 132,023 | Feb 19, 2026 |
| Dec 1, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +6,209 | $0.00 | $0 | 124,461 | Dec 3, 2025 |
| Sep 1, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +4,970 | $0.00 | $0 | 118,252 | Sep 5, 2025 |
| Jul 9, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +36,231 | $0.00 | $0 | 113,282 | Jul 10, 2025 |
| Jun 1, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +4,080 | $0.00 | $0 | 77,051 | Jun 3, 2025 |
| Mar 1, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +3,033 | $0.00 | $0 | 72,971 | Mar 4, 2025 |
| Dec 30, 2024 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock10b5-1 | -4,500 | $6.93 | $31k | 69,938 | Jan 2, 2025 |
| Dec 23, 2024 | HCAT Health Catalyst, Inc. | SOpen-market sale Common Stock10b5-1 | -4,500 | $6.98 | $31k | 74,438 | Dec 27, 2024 |
| Dec 1, 2024 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +2,001 | $0.00 | $0 | 78,938 | Dec 3, 2024 |
Questions about Duncan Gallagher
Answered from the filings on this page, as of the latest one.
Is Duncan Gallagher buying or selling?
Not in the last 12 months. Duncan Gallagher's latest open-market trade on SEC Form 4 was sold $31k of HCAT on Dec 30, 2024.
How did Duncan Gallagher's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Duncan Gallagher has 0.
Where does Duncan Gallagher file Form 4?
Duncan Gallagher has filed Form 4 at HCAT (Health Catalyst, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.